Introduction
============

Peri-implantitis is a destructive inflammatory disease that affects the tissues surrounding dental implants ([@b1-etm-0-0-4176],[@b2-etm-0-0-4176]). It has been demonstrated that peri-implantitis is a crucial element in implant failure. In total, \~30% of patients that receive dental implants develop peri-implantitis ([@b3-etm-0-0-4176]). However, there are currently no effective therapeutic strategies against peri-implantitis. Moreover, the use of dental implants is constantly increasing, therefore an effective therapy to treat peri-implantitis is required. Thus, further investigations into the molecular pathophysiology of peri-implantitis are necessary in order to provide novel options for effective treatment ([@b1-etm-0-0-4176]).

Recently, a number of studies have investigated the pathological mechanisms underlying peri-implantitis progression. Becker *et al* ([@b4-etm-0-0-4176]) indicated that serglycin (*SRGN*) expression was significantly upregulated in peri-implantitis when compared with healthy individuals. It has been suggested that this gene may inhibit bone mineralization *in vitro* ([@b5-etm-0-0-4176]). Another study indicated that concentrations of the nuclear factor-κB (NF-B), soluble RANK ligand (sRANKL), osteoprotegerin (OPG) and sclerostin are significantly increased in patients with peri-implantitis ([@b6-etm-0-0-4176]). A number of typical bone matrix molecules, including collagen, type IX, α 1 (COL9A1), bone gamma-carboxyglutamate (Gla) protein (BGLAP) and secreted phosphoprotein 1 (SPP1) are decreased in the peri-implantitis tissues ([@b1-etm-0-0-4176]). Furthermore, it has been identified that fibroblasts are involved in the pathogenesis of peri-implantitis ([@b7-etm-0-0-4176]). The regulation of inflammatory mediators and matrix metalloproteinases (MMPs) in peri-implantitis fibroblasts function in the pathogenesis of the disease ([@b8-etm-0-0-4176]), and levels of the anti-inflammatory cytokine interleukin (IL)-10 are decreased in peri-implantitis ([@b9-etm-0-0-4176]). Furthermore, peroxisome proliferator-activated receptor γ (PPARγ) that can inhibit inflammation and promote osteoblast function is downregulated in the peri-implantitis tissues ([@b10-etm-0-0-4176]). However, other mechanisms associated with peri-implantitis have not been identified. Therefore, further research should focus on elucidating other potential mechanisms and investigate target genes for the treatment of peri-implantitis.

The microarray data of GSE57631 was used to confirm the similarities and differences of inflamed peri-implantitis tissues vs. normal peri-implantitis tissues at the mRNA level ([@b1-etm-0-0-4176]). In contrast to results from a previous study ([@b1-etm-0-0-4176]), the array data of GSE57631 was downloaded and the differentially expressed genes (DEGs) associated with peri-implantitis were analyzed using a biological informatics approach. In addition, functional enrichment analyses were performed for DEGs. In addition, a protein-protein interaction (PPI) network was established and four significant modules were analyzed. The present study aimed to identify the key genes and pathways of peri-implantitis, and identify possible significant mechanisms associated with it.

Materials and methods
=====================

### Affymetrix microarray data

The array data of GSE57631 was downloaded from the Gene Expression Omnibus (GEO; <http://www.ncbi.nlm.nih.gov/geo/>) database, which was deposited by Schminke *et al* ([@b1-etm-0-0-4176]). Six samples of peri-implantitis tissues and two samples of normal tissues were included in the present study. The raw data and annotation files were downloaded for subsequent analysis, based on the GPL15034 platform (Affymetrix Human Gene 1.0 ST Array \[HuGene10stv1_Hs_ENTREZ, Brainarray v14\]; Affymetrix, Inc., Santa Clara, CA, USA).

### Data preprocessing

The raw expression data was preprocessed using the robust multiarray average ([@b11-etm-0-0-4176]) algorithm by applying an oligo ([@b12-etm-0-0-4176]) in the R statistical software program in Bioconductor (<http://www.bioconductor.org/>). Background correction, normalization and a calculating expression were included in the process of preprocessing. A total of 18,977 gene expression values were obtained.

### DEG analysis

The limma package ([@b13-etm-0-0-4176]) in Bioconductor was used to analyze DEGs in peri-implantitis samples compared with controls. In the process of the analysis, the P-values of DEGs were calculated using a t-test in the limma package. \|log2FC\|≥1 and P\<0.05 were used as a cut-off criteria.

### Gene Ontology (GO) and pathway enrichment analyses

GO is a tool that is used for gene annotation by collecting defined, structured, controlled vocabulary, which includes three main categories: Molecular function (MF), biological process (BP) and cellular component (CC) ([@b14-etm-0-0-4176]). Kyoto Encyclopedia of Genes and Genomes (KEGG) is a database used for associating related gene sets with their pathways ([@b15-etm-0-0-4176]). Moreover, DAVID, an integrated data-mining environment, is used to analyze gene lists ([@b16-etm-0-0-4176]).

GO annotation and KEGG pathway enrichment analyses were conducted for upregulated and downregulated genes by DAVID. Moreover, EASE ≤0.05 and gene counts ≥ were set as the threshold value.

### PPI network analysis

The Search Tool for the Retrieval of Interacting Genes (STRING) ([@b17-etm-0-0-4176]) database provides information regarding the predicted and experimental interactions of proteins. The prediction method of this database came from neighborhood, gene fusion, co-occurrence, co-expression experiments, databases and text mining. Moreover, the interactions of protein pairs in the database are presented with a combined score. In the present study, DEGs were mapped into PPIs and a combined score of \>0.9 was used as the cut-off value. In addition, PPI networks were constructed using Cytoscape software version 3.2.1 ([@b18-etm-0-0-4176]).

Topological properties of the PPI network, including degree ([@b19-etm-0-0-4176]), subgraph ([@b20-etm-0-0-4176]) and betweenness ([@b21-etm-0-0-4176]) centralities were determined using the R software package igraph ([@b22-etm-0-0-4176]), in order to analyze key genes in the network. A degree was used for describing the importance of protein nodes in the network. Subgraph centrality based on combining network topology and information of protein complexes was used to measure the importance of nodes in the network. The higher the degree and subgraph values were, the more important the nodes were in the network. Moreover, the betweenness centrality is an index describing the global topological properties of the network and could be used to describe how the nodes affect the connectivity between two nodes. Betweenness was defined as the ratio of the number of every path passed per node and the number of the shortest paths. The higher the betweenness values are, the greater the impact of the node in the network is. In addition, R software package igraph version 1.0.1 ([@b22-etm-0-0-4176]) was used for these three methods.

### Module analysis

Network module was one of the characteristics of the protein network and may contain specific biological significance. The Cytoscape software package Molecular Complex Detection (MCODE) ([@b23-etm-0-0-4176]) was used to analyze the most notable clustering module. Next, the KEGG pathway enriched by DEGs in different modules was analyzed using DAVID online tool. EASE ≤0.05 and count ≥2 were set as the cutoff values.

Results
=======

### Data processing and DEG analysis

As shown in [Fig. 1](#f1-etm-0-0-4176){ref-type="fig"}, a total of 819 DEGs including 759 upregulated and 60 downregulated genes, were identified in the peri-implantitis samples compared with the control ones. As a result, the number of upregulated genes was found to be significantly higher than that of the downregulated ones.

### GO and pathway enrichment analyses

GO and KEGG pathway analyses were performed for upregulated and downregulated DEGs, respectively. The GO terms of upregulated DEGs were mainly associated with the proteasomal protein catabolic process, endoplasmic reticulum, melanosome and structural constituent of the cytoskeleton ([Table IA](#tI-etm-0-0-4176){ref-type="table"}). The downregulated DEGs were mainly enriched in the epidermis and ectoderm development, and the extracellular region part and cadmium ion binding ([Table IB](#tI-etm-0-0-4176){ref-type="table"}).

Two pathways that were significantly enriched by upregulated DEGs were Alzheimer\'s disease and the proteasome ([Table II](#tII-etm-0-0-4176){ref-type="table"}). Moreover, an important gene *HSP90AA1* was significantly enriched in the antigen processing and presentation pathway and the nucleotide-binding oligomerization domain (NOD)-like receptor signaling pathway, and *NFKB1* was enriched in NOD-like receptor signaling pathway in KEGG pathway enrichment analysis for upregulated genes. However, downregulated DEGs did not significantly enriched any pathways.

### PPI network analysis

Based on the STRING database, a total of 413 nodes and 1,114 protein pairs were obtained with a combined score \>0.9 ([Fig. 2](#f2-etm-0-0-4176){ref-type="fig"}). As shown in [Fig. 2](#f2-etm-0-0-4176){ref-type="fig"}, the majority of the nodes in the network were upregulated DEGs in peri-implantitis samples. The top 20 most up- and dowregulated nodes are presented in [Table III](#tIII-etm-0-0-4176){ref-type="table"}. A number of protein enzyme families, such as the proteasome subunit, α type 1 (PSMA1), proteasome subunit, beta type 1 (PSMB1) and proteasome subunit, α type 4 (PSMA4) were hub nodes based on the subgraph and degree centralities. Heat shock protein *HSP90AA1* (90 kDa α, member 1), Ras-related C3 botulinum toxin substrate 1, NFKB1, Jun proto-oncogene were hub nodes with higher betweenness values.

### Module analysis

In total, four modules (modules 1, 2, 3 and 4) with score \>6 were detected by MCODE ([Fig. 3](#f3-etm-0-0-4176){ref-type="fig"}). As shown in [Table IV](#tIV-etm-0-0-4176){ref-type="table"}, *PSMA1*, *PSMA4* and PSMB1 were hub nodes with higher node degrees in module 1, and ribophorin 1 (*RPN1*), ribophorin 2 (*RPN2*) and dolichyl-diphosphooligosaccharide-protein glycosyltransferase subunit (*DDOST*) were hub nodes in module 2. The hub nodes with higher node degrees in module 3 were pre-mRNA processing factor 8 (*PRPF8*), small nuclear ribonucleoprotein D1 polypeptide (*SNRPD1*; 16 kDa) and small nuclear ribonucleoprotein polypeptides B and B1 (*SNRPB*), and the hub nodes in module 4 were HSP90AA1, ATP synthase, H^+^ transporting, mitochondrial Fo complex, Subunit F2 (*ATP5J2*) and ATP synthase, H^+^ transporting, mitochondrial F1 complex and beta polypeptide (*ATP5B*). Furthermore, the proteasome pathway was identified as the most significant pathway in module 1.

Discussion
==========

In the present study, the gene expression patterns obtained from the GEO database revealed a total of 819 genes, including 759 upregulated and 60 downregulated genes, that were differently expressed in peri-implantitis samples compared with controls. The results of the present study demonstrated that *HSP90AA1*, which had the highest degrees in the PPI network, was significantly identified in module 4. In addition, *NFKB1* were also hub nodes with higher betweenness values in the PPI network. Moreover, the proteasome pathway was the most significant pathway in module 1, and may be key mechanisms associated with peri-implantitis progression.

HSP90, a member of the heat shock family of proteins, is essential in determining cell cycle control and survival, hormone and a number of signaling pathways ([@b24-etm-0-0-4176]). In addition, released HSP90, which functions as a danger signal, can elicit secretion of inflammatory cytokines ([@b25-etm-0-0-4176]). A cell-impermeable HSP90 inhibitor can prevent inflammatory responses, indicating that extracellular HSP90 is involved in mediating and initiating sterile inflammatory responses ([@b26-etm-0-0-4176]). Moreover, previous data indicate that HSP90-targeted agents may be helpful for the treatment of inflammatory disease, and that an HSP90 inhibitor can affect multiple signaling processes associated with inflammation ([@b27-etm-0-0-4176]). Furthermore, inhibition of HSP90 is able to reduce innate immunity responses and diminishes proinflammatory mediator production in immune-stimulated macrophages ([@b28-etm-0-0-4176],[@b29-etm-0-0-4176]). In addition, analysis of inflammatory mediators in crevicular fluid can be used to distinguish peri-implantitis from normal tissue ([@b30-etm-0-0-4176]).

Systemic markers of inflammation are increased in patients with peri-implantitis ([@b30-etm-0-0-4176]) and high levels of inflammatory cytokines, such as IL-1β, are associated with signs of early peri-implantitis development ([@b31-etm-0-0-4176]--[@b33-etm-0-0-4176]). Furthermore, it has been suggested that fibroblasts express HSP90 that also participates in the pathogenesis of peri-implantitis ([@b7-etm-0-0-4176],[@b34-etm-0-0-4176]). Moreover, HSPs together with vascular and inflammatory biomarkers may be useful as biomarkers of peri-implantitis development ([@b35-etm-0-0-4176],[@b36-etm-0-0-4176]). In the present study, *HSP90AA1*, a hub node with higher node degrees in module 4, was enriched in antigen processing and the presentation pathway, as well as the NOD-like receptor-signaling pathway. Therefore, the results of the present study are in line with results from former previous studies and indicate that *HSP90AA1* may be directly or indirectly important in peri-implantitis development.

In the present study, *NFKB1* was shown to also have hub nodes with higher betweenness values in the PPI network. The *NFKB1* gene is known to encode the NF-KB p105/p50 isoforms ([@b37-etm-0-0-4176]). The central pathological pattern of peri-implantitis is inflammatory osteoclastogenesis, which is mediated by proinflammatory mediators and performed by the regulators of osteoclastogenesis, including NF-B, sRANKL and OPG ([@b38-etm-0-0-4176],[@b39-etm-0-0-4176]). A prior study indicated that the NF-B concentration increased 1.5--4-fold in patients with peri-implantitis compared to those with mucositis ([@b6-etm-0-0-4176]). Moreover, recent studies demonstrated that high levels of NF-B were associated with peri-implantitis ([@b40-etm-0-0-4176],[@b41-etm-0-0-4176]). In addition, NF-B is upregulated in inflammatory bowel disease and is a transcription regulator of the immune response ([@b42-etm-0-0-4176]). Zou *et al* ([@b43-etm-0-0-4176]) reported that NFKB1 could regulate the transcription of genes in the immune response, and was also a key part in coordinating the immune system. Numerous studies have indicated that the NFKB1-94ins/del ATTG promoter polymorphism is associated with inflammatory disease ([@b37-etm-0-0-4176],[@b42-etm-0-0-4176],[@b44-etm-0-0-4176],[@b45-etm-0-0-4176]). Furthermore, as mentioned in the aforementioned paragraph, inflammation is associated with the pathogenesis of peri-implantitis. Therefore, the results of the present study are in accordance with those from previous studies and suggest that *NFKB1* may be a key gene associated with peri-implantitis development. Notably in the current study, *HSP90AA1* and NFKB1 were enriched in the NOD-like receptor-signaling pathway. Although the important roles of the NOD-like receptor-signaling pathway have not been fully discussed, it is speculated that *HSP90AA1* and NFKB1 may be involved in peri-implantitis progression via the NOD-like receptor-signaling pathway.

In addition to the two aforementioned genes, the proteasome pathway containing the proteasome subunits (*PSM) A1*, *PSMA3*, *PSMA4*, *PSMB1*, *PSMB3*, *PSMB4*, *PSMB6*, *PSMC2*, *PSMD8*, *PSME3* and *PSME4*, were found to be enriched in the most significant pathway in module 1 and to have the highest P-value. Elliott *et al* ([@b46-etm-0-0-4176]) indicated that key proteins modulated by the proteasome were involved in controlling inflammatory processes. A prior study demonstrated that the activation of the ubiquitin-proteasome by macrophages is involved in an NF-B-dependent increase in inflammation ([@b47-etm-0-0-4176]). Moreover, previous studies have indicated that the proteasomal pathway as a targeting goal may be a potential way to treat autoimmune and inflammatory diseases ([@b48-etm-0-0-4176]--[@b50-etm-0-0-4176]). In addition, Wang and Maldonado ([@b51-etm-0-0-4176]) demonstrated that proteasome inhibitors could serve as novel drugs by regulating proinflammatory protein catabolism. Furthermore, as stated above, inflammation has been associated with the pathogenesis of peri-implantitis. Finally, the *PSMA1*, *PSMA3*, *PSMA4*, *PSMB1*, *PSMB3*, *PSMB4*, *PSMB6*, *PSMC2*, *PSMD8*, *PSME3* and *PSME4* proteins are essential subunits that contribute to the assembly of the proteasome complex ([@b52-etm-0-0-4176]--[@b55-etm-0-0-4176]). Therefore, the proteasome and its subunit genes may be important in peri-implantitis progression.

In conclusion, *HSP90AA1*, *NFKB1* and the NOD-like receptor signaling pathway, as well as the proteasome pathway and its subunits genes may be important in the development of peri-implantitis. However, there were certain limitations in the present study, such as no experimental verification and the relatively small sample size used. Therefore, further research investigating the potential mechanisms involved in peri-implantitis are required.

![Heat map of differentially expressed genes. Green represents a lower expression level, red represents higher expression levels and black represents that there is no differential expression amongst the genes.](etm-13-05-1832-g00){#f1-etm-0-0-4176}

![Protein-protein interaction network of differentially expressed genes in peri-implantitis samples compared with the control ones. Red nodes, upregulated genes; green nodes, downregulated genes.](etm-13-05-1832-g01){#f2-etm-0-0-4176}

![Four significant modules identified from the protein-protein interaction network using the molecular complex detection method with a score of \>6.0. Module 1: MCODE score=19.238; Module 2: MCODE score=11.333; Module 3: MCODE score=9 and Module 4: MCODE score=6.316.](etm-13-05-1832-g02){#f3-etm-0-0-4176}

###### 

GO for differentially expressed genes.

  A, Upregulated                                                                          
  ------------------ ----------------------------------------------------------- -------- --------------
  GO-BP                                                                                   
    GO: 0010498      Proteasomal protein catabolic process                         24     5.32×10^−11^
    GO: 0043161      Proteasomal ubiquitin-dependent protein catabolic process     24     5.32×10^−11^
    GO: 0032269      Negative regulation of cellular protein metabolic process     30     9.32×10^−10^
  GO-CC                                                                                   
    GO: 0005783      Endoplasmic reticulum                                       115      1.37×10^−21^
    GO: 0042470      Melanosome                                                    30     1.77×10^−17^
    GO: 0048770      Pigment granule                                               30     1.77×10^−17^
  GO-MF                                                                                   
    GO: 0005200      Structural constituent of cytoskeleton                        15     2.22×10^−6^
    GO: 0070003      Threonine-type peptidase activity                             8      1.13×10^−5^
                                                                                          
  B, Downregulated                                                                        
                                                                                          
  Terms              Description                                                 Counts   P-value
                                                                                          
  GO-BP                                                                                   
    GO:0008544       Epidermis development                                       20       2.57×10^−10^
    GO:0007398       Ectoderm development                                        20       9.84×10^−10^
    GO:0006954       Inflammatory response                                       19       9.40×10^−6^
  GO-CC                                                                                   
    GO:0044421       Extracellular region part                                   35       1.05×10^−5^
    GO:0005576       Extracellular region                                        54       1.33×10^−4^
    GO:0005615       Extracellular space                                         25       2.79×10^−4^
  GO-MF                                                                                   
    GO:0046870       Cadmium ion binding                                           4      5.27×10^−4^
    GO:0005507       Copper ion binding                                            6      6.22×10^−3^

Terms represent the identification number of GO term; description represents the names of GO term; counts represent the number of genes enriched in GO terms. GO, Gene ontology; BP, biological process; CC: cellular component; MF, molecular function.

###### 

KEGG pathway enrichment analysis for upregulated differentially expressed genes.

  Term       Description                               Counts   P-value
  ---------- ----------------------------------------- -------- -------------
  hsa05010   Alzheimer\'s disease                      25       1.69×10^−5^
  hsa03050   Proteasome                                12       5.36×10^−5^
  hsa00190   Oxidative phosphorylation                 18       1.19×10^−3^
  hsa05012   Parkinson\'s disease                      17       2.65×10^−3^
  hsa05016   Huntington\'s disease                     21       3.41×10^−3^
  hsa00510   N-Glycan biosynthesis                       9      4.31×10^−3^
  hsa04142   Lysosome                                  15       7.11×10^−3^
  hsa00480   Glutathione metabolism                      9      7.27×10^−3^
  hsa04612   Antigen processing and presentation       12       7.74×10^−3^
  hsa04621   NOD-like receptor signaling pathway       10       8.63×10^−3^
  hsa00970   Aminoacyl-tRNA biosynthesis                 7      2.89×10^−2^
  hsa00020   Citrate cycle (TCA cycle)                   6      3.07×10^−2^
  hsa01040   Biosynthesis of unsaturated fatty acids     5      3.51×10^−2^
  hsa05130   Pathogenic *Escherichia coli* infection     8      4.45×10^−2^

Term represents the identification number of the KEGG pathway; Description represents the name of the KEGG pathway; Counts represent the number of genes enriched in the KEGG pathway. KEGG, Kyoto Encyclopedia of Genes and Genomes; NOD, nucleotide-binding oligomerization domain-like; TCA, tricarboxylic acid.

###### 

Nodes with higher values in subgraph centrality, betweenness centrality and degree centrality.

  Nodes     Subgragh     Nodes      Betweenness   Nodes      Degree
  --------- ------------ ---------- ------------- ---------- --------
  PSMA1     2.35×10^7^   HSP90AA1   2.78×10^4^    HSP90AA1   34
  PSMB1     2.32×10^7^   RAC1       1.77×10^4^    JUN        27
  PSMA4     2.31×10^7^   NFKB1      1.38×10^4^    RAC1       27
  PSMB4     2.30×10^7^   JUN        1.21×10^4^    PSMA1      25
  PSMA3     2.30×10^7^   HIF1A      1.07×10^4^    PSMA4      25
  PSMB3     2.30×10^7^   CDH1       9.21×10^3^    PSMB1      25
  PSMB6     2.30×10^7^   SOS1       8.93×10^3^    PSMC2      25
  PSMC2     2.16×10^7^   CANX       8.55×10^3^    PSMB4      24
  PSMD8     2.12×10^7^   HDAC1      8.35×10^3^    PSMA3      24
  PSMD5     2.08×10^7^   ATP5B      8.24×10^3^    PSMB3      24
  PSME4     2.08×10^7^   GTF2B      8.17×10^3^    PSMB6      24
  PSMD10    2.04×10^7^   HSPA5      7.84×10^3^    PSMD10     24
  PSME3     1.96×10^7^   STAT3      7.46×10^3^    PSMD8      23
  UBE2D1    1.54×10^7^   VCP        7.32×10^3^    SEC61A1    23
  CDC16     1.36×10^7^   RPS5       7.14×10^3^    RPN2       23
  ANAPC5    1.36×10^7^   NME1       6.31×10^3^    NFKB1      23
  BUB3      1.35×10^7^   POLR2B     5.90×10^3^    PSMD5      22
  SEC61A1   1.23×10^7^   P4HB       5.90×10^3^    PSME4      22
  SKP1      1.16×10^7^   TXN        5.67×10^3^    UBE2D1     22
  HSPB1     1.05×10^7^   RPN2       5.67×10^3^    RPN1       22

PSM, proteasome subunit.

###### 

KEGG pathway enriched by differentially expressed genes in different modules (P\<0.05).

  Term         Description                           P-value        Genes
  ------------ ------------------------------------- -------------- -------------------------------------------------------------------------------
  Module1                                                           
    hsa03050   Proteasome                            6.77×10^−17^   *PSMB4, PSMA1, PSMB6, PSMB1, PSMC2, PSMA4, PSMB3, PSMA3, PSME3, PSME4, PSMD8*
    hsa04110   Cell cycle                            9.03×10^−3^    *ANAPC5, SKP1, CDC16, BUB3*
    hsa04120   Ubiquitin mediated proteolysis        1.16×10^−2^    *ANAPC5, SKP1, CDC16, UBE2D1*
  Module2                                                           
    hsa00510   N-Glycan biosynthesis                 1.63×10^−3^    *RPN1, RPN2, DDOST*
    hsa03060   Protein export                        1.10×10^−2^    *SRP68, SRP72*
  Module3                                                           
    hsa03040   Spliceosome                           5.19×10^−6^    *PRPF8, SNRPD1, SNRPB, TXNL4A, SF3A3*
    hsa03020   RNA polymerase                        3.26×10^−2^    *POLR2H, POLR2B*
  Module4                                                           
    hsa00190   Oxidative phosphorylation             1.68×10^−5^    *ATP5J2, ATP5B, ATP5C1, ATP5G1, ATP5H, PPA1*
    hsa04612   Antigen processing and presentation   1.34×10^−3^    *HSP90AB1, HSP90AA1, IFI30, HLA-DRB5*
    hsa05012   Parkinson\'s disease                  4.63×10^−3^    *ATP5B, ATP5C1, ATP5G1, ATP5H*
    hsa05010   Alzheimer\'s disease                  9.07×10^−3^    *ATP5B, ATP5C1, ATP5G1, ATP5H*
    hsa05016   Huntington\'s disease                 1.19×10^−2^    *ATP5B, ATP5C1, ATP5G1, ATP5H*
    hsa04514   Cell adhesion molecules               5.00×10^−2^    *NCAM1, ICAM1, HLA-DRB5*

Term represents the identification number of the KEGG pathway; description represents the name of the KEGG pathway. KEGG, Kyoto Encyclopedia of Genes and Genomes.
